why choose us

First received: December 27, 2022

Clinical Trial: A Study of Participants With Chronic Kidney Disease Previously Treated With REACT

Study Status: Completed

Recruit Status: RECRUITING

Condition: Diabetic Kidney Disease

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Open-label, Supplemental Dosing Study of Participants With Chronic Kidney Disease Previously Treated With REACT (REGEN-015)

Brief Summary: The purpose of this study is to evaluate the safety of supplemental REACT injections in participants with chronic kidney disease (CKD) who have previously received REACT treatment.

Read more